Sponsored Links
| Medicago Receives Regulatory Approval To Begin Human Clinical Testing With Its Avian Flu Pandemic Vaccine |
 |
 |
 |
| Medical News - Bird Flu | |||
|
Medicago Inc. (TSX VENTURE:MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced that it has received clearance from Health Canada to commence a Phase I human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrollment of volunteers is now underway. Read more: Bird Flu / Avian Flu News From Medical News Today
|